Cite
HARVARD Citation
Schlafstein, A. et al. (2018). CDK9 Expression Shows Role as a Potential Prognostic Biomarker in Breast Cancer Patients Who Fail to Achieve Pathologic Complete Response after Neoadjuvant Chemotherapy. International journal of breast cancer. p. . [Online].